Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

kamada ltd, israel - rupatadine as fumarate - tablets - rupatadine as fumarate 10 mg - rupatadine - rupafin is indicated for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years of age)

Israel - English - Ministry of Health

rafa laboratories ltd - metoclopramide hydrochloride - tablets - metoclopramide hydrochloride 10 mg - metoclopramide - metoclopramide - metoclopramide is an antiemetic and stimulates gi motility. adult population :pramin is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv)- prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)- prevention of nausea and vomiting caused by radiation therapy- symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption.- diabetic gastroparesis pediatric population:pramin is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv)- second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)

Israel - English - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

Israel - English - Ministry of Health

novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 500 mg - mesalazine - mesalazine - mild to moderate ulcerative colitis.crohn's disease

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mesalazine - mild to moderate ulcerative colitis. crohn's disease.

Israel - English - Ministry of Health

merck sharp & dohme israel ltd - alendronic acid as alendronate sodium trihydrate; colecalciferol - tablets - colecalciferol 140 mcg; alendronic acid as alendronate sodium trihydrate 70 mg - colecalciferol - colecalciferol - fosavance is indicated for : - treatment of osteoporosis in postmenopausal women: fosavance increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). - treatment to increase bone mass in men with osteoporosis.